PURPOSE: To report the serial evaluation of asymptomatic eyes of subjects with mutated G11778A mitochondrial DNA. METHODS: Forty-five asymptomatic G11778A Leber hereditary optic neuropathy (LHON) carriers and two patients with the mutation who developed unilateral visual loss underwent testing that included visual acuity, automated visual field, pattern electroretinogram (PERG), and spectral-domain optical coherence tomography every 6 months between September 2008 and March 2012. RESULTS: Visual acuity, visual fields, and retinal nerve fiber layer thickness remained stable within the normal range. Mean PERG amplitudes of carriers dropped progressively by ∼ 40% from baseline to 36 months. In addition, comparisons with the fellow eyes of patients with unilateral optic neuritis revealed a 3.4 ETDRS (Early Treatment Diabetic Retinopathy Study) letter loss in the LHON carriers. A single carrier developed visual loss, with PERG amplitudes dropping by half. In one of two LHON cases who presented with unilateral visual loss, visual acuity in the asymptomatic eye was ∼ 20/40 at baseline. The PERG amplitude of this eye was reduced to ∼ 30% of normal. Six months later, his visual acuity had dropped to ∼ 20/500. A second patient who was ∼ 20/20 and had a visual field defect in the asymptomatic eye at baseline remained at this level for the 18 months of follow-up. His PERG amplitudes were similar to those of asymptomatic carriers, with 0.78 μV at baseline that did not decline with follow-up. CONCLUSIONS: Declines of the PERG amplitude suggest subclinical retinal ganglion cell dysfunction in asymptomatic G11778A subjects, which is progressive.
PURPOSE: To report the serial evaluation of asymptomatic eyes of subjects with mutated G11778A mitochondrial DNA. METHODS: Forty-five asymptomatic G11778ALeber hereditary optic neuropathy (LHON) carriers and two patients with the mutation who developed unilateral visual loss underwent testing that included visual acuity, automated visual field, pattern electroretinogram (PERG), and spectral-domain optical coherence tomography every 6 months between September 2008 and March 2012. RESULTS: Visual acuity, visual fields, and retinal nerve fiber layer thickness remained stable within the normal range. Mean PERG amplitudes of carriers dropped progressively by ∼ 40% from baseline to 36 months. In addition, comparisons with the fellow eyes of patients with unilateral optic neuritis revealed a 3.4 ETDRS (Early Treatment Diabetic Retinopathy Study) letter loss in the LHON carriers. A single carrier developed visual loss, with PERG amplitudes dropping by half. In one of two LHON cases who presented with unilateral visual loss, visual acuity in the asymptomatic eye was ∼ 20/40 at baseline. The PERG amplitude of this eye was reduced to ∼ 30% of normal. Six months later, his visual acuity had dropped to ∼ 20/500. A second patient who was ∼ 20/20 and had a visual field defect in the asymptomatic eye at baseline remained at this level for the 18 months of follow-up. His PERG amplitudes were similar to those of asymptomatic carriers, with 0.78 μV at baseline that did not decline with follow-up. CONCLUSIONS: Declines of the PERG amplitude suggest subclinical retinal ganglion cell dysfunction in asymptomatic G11778A subjects, which is progressive.
Entities:
Keywords:
Leber hereditary optic neuropathy; electrophysiology; mitochondrial DNA
Authors: Vittorio Porciatti; Brandon Bosse; Prashant K Parekh; Olga A Shif; William J Feuer; Lori M Ventura Journal: J Glaucoma Date: 2014 Oct-Nov Impact factor: 2.503
Authors: Thomas Klopstock; Patrick Yu-Wai-Man; Konstantinos Dimitriadis; Jacinthe Rouleau; Suzette Heck; Maura Bailie; Alaa Atawan; Sandip Chattopadhyay; Marion Schubert; Aylin Garip; Marcus Kernt; Diana Petraki; Christian Rummey; Mika Leinonen; Günther Metz; Philip G Griffiths; Thomas Meier; Patrick F Chinnery Journal: Brain Date: 2011-07-25 Impact factor: 13.501
Authors: T Klopstock; G Metz; P Yu-Wai-Man; B Büchner; C Gallenmüller; M Bailie; N Nwali; P G Griffiths; B von Livonius; L Reznicek; J Rouleau; N Coppard; T Meier; P F Chinnery Journal: Brain Date: 2013-02-06 Impact factor: 13.501
Authors: Thomas R Hedges; Marisa Gobuty; Richard A Manfready; Natalie Erlich-Malona; Caitlin Monaco; Carlos E Mendoza-Santiesteban Journal: Neuroophthalmology Date: 2016-05-02
Authors: Gregory J Tranah; Kristine Yaffe; Shana M Katzman; Ernest T Lam; Ludmila Pawlikowska; Pui-Yan Kwok; Nicholas J Schork; Todd M Manini; Stephen Kritchevsky; Fridtjof Thomas; Anne B Newman; Tamara B Harris; Anne L Coleman; Michael B Gorin; Elizabeth P Helzner; Michael C Rowbotham; Warren S Browner; Steven R Cummings Journal: J Gerontol A Biol Sci Med Sci Date: 2015-08-31 Impact factor: 6.053
Authors: William J Feuer; Joyce C Schiffman; Janet L Davis; Vittorio Porciatti; Phillip Gonzalez; Rajeshwari D Koilkonda; Huijun Yuan; Anil Lalwani; Byron L Lam; John Guy Journal: Ophthalmology Date: 2015-11-19 Impact factor: 12.079
Authors: Nancy J Newman; Patrick Yu-Wai-Man; Valerio Carelli; Valerie Biousse; Mark L Moster; Catherine Vignal-Clermont; Robert C Sergott; Thomas Klopstock; Alfredo A Sadun; Jean-François Girmens; Chiara La Morgia; Adam A DeBusk; Neringa Jurkute; Claudia Priglinger; Rustum Karanjia; Constant Josse; Julie Salzmann; François Montestruc; Michel Roux; Magali Taiel; José-Alain Sahel Journal: Front Neurol Date: 2021-05-24 Impact factor: 4.003
Authors: Maja Kostic; Phillip Gordon; Pedro Monsalve; Hong Jang; Byron L Lam; John Guy; John McSoley; Luis Vazquez; Elizabeth Hodapp; Vittorio Porciatti Journal: Curr Eye Res Date: 2020-06-04 Impact factor: 2.424